Literature DB >> 19824951

Disturbed prepulse inhibition in patients with schizophrenia is consequential to dysfunction of selective attention.

Kirsty E Scholes1, Mathew T Martin-Iverson.   

Abstract

Controversy exists as to the cause of disturbed prepulse inhibition (PPI) in patients with schizophrenia. This study aimed to clarify the nature of PPI in schizophrenia using improved methodology. Startle and PPI were measured in 44 patients with schizophrenia and 32 controls across a range of startling stimulus intensities under two conditions, one while participants were attending to the auditory stimuli (ATTEND condition) and one while participants completed a visual task in order to ensure they were ignoring the auditory stimuli (IGNORE condition). Patients showed reduced PPI of R(MAX) (reflex capacity) and increased PPI of Hillslope (reflex efficacy) only under the INGORE condition, and failed to show the same pattern of attentional modulation of the reflex parameters as controls. In conclusion, disturbed PPI in schizophrenia appears to result from deficits in selective attention, rather than from preattentive dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19824951     DOI: 10.1111/j.1469-8986.2009.00927.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  18 in total

1.  Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits.

Authors:  Kirsty Elizabeth Scholes; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2009-10-09       Impact factor: 4.530

Review 2.  Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.

Authors:  Timothy P Rutkowski; Jason P Schroeder; Georgette M Gafford; Stephen T Warren; David Weinshenker; Tamara Caspary; Jennifer G Mulle
Journal:  J Neurosci Res       Date:  2016-11-08       Impact factor: 4.164

3.  Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats.

Authors:  Avdesh Avdesh; Vincent Cornelisse; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

Review 4.  Influence of emotional states on inhibitory gating: animals models to clinical neurophysiology.

Authors:  Howard C Cromwell; Rachel M Atchley
Journal:  Behav Brain Res       Date:  2014-05-23       Impact factor: 3.332

5.  Individual difference in prepulse inhibition does not predict spatial learning and memory performance in C57BL/6 mice.

Authors:  Daria Peleg-Raibstein; Singer Philipp; Joram Feldon; Benjamin K Yee
Journal:  Cogn Affect Behav Neurosci       Date:  2015-12       Impact factor: 3.282

Review 6.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

7.  Lack of relationship between acoustic startle and cognitive variables in schizophrenia and control subjects.

Authors:  Wendy Hasenkamp; Mary Kelley; Glenn Egan; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2011-03-11       Impact factor: 3.222

8.  Dexamphetamine effects on prepulse inhibition (PPI) and startle in healthy volunteers.

Authors:  Kate Chitty; Matthew A Albrecht; Kyran Graham; Chantelle Kerr; Joseph W Y Lee; Rajan Iyyalol; Mathew T Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2013-12-18       Impact factor: 4.530

9.  Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.

Authors:  Steven M Silverstein; Yushi Wang; Brian P Keane
Journal:  Front Psychol       Date:  2013-01-21

10.  Neuropeptide S-Mediated Modulation of Prepulse Inhibition Depends on Age, Gender, Stimulus-Timing, and Attention.

Authors:  Wei Si; Xiaobin Liu; Hans-Christian Pape; Rainer K Reinscheid
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.